OBSERVATION of the microcirculation of the hamster cheek pouch by intravital microscopy revealed five steps of neutrophil migration from the venules after topical application of leukotriene B to the microvasculature: rolling along the venular wall (Step 1), adhesion to it (Step 2), disappearance from the vascular lumen (Step 3), presence between the endothelial cells and the subendothelial basement membrane (Step 4) and passage through the basement membrane (Step 5). The present study was performed to examine whether a metalloproteinase inhibitor inhibits neutrophil migration at any of the above five steps. Chymostatin and leupeptin did not inhibit any of these five steps. In contrast, FN-439, a selective inhibitor of matrix metalloproteinase, reduced the number of neutrophils in the perivascular space without affecting Steps 1 to 3. It was concluded that neutrophils may use metalloproteinase (collagenase/gelatinase) to penetrate the subendothelial basement membrane.
Introduction
Migration of polymorphonuclear leukocytes, mainly neutrophils, from the circulation to the extravascular space is one of the cardinal signs of the acute inflammatory response. A study of chemoattractant-induced migration of neutrophils in the microcirculation of the hamster cheek pouch by intravital microscopy has demonstrated five steps from the circulation to the extravascular space. Once chemoattractants such as leukotriene (LT) B or fMLP (N-formyl-methionyl-leucyl-phenylalanine) are applied over the mirovasculature, neutrophil numbers rolling on the inner surface of the venules did not always increase, compared with that before chemoattractants ( Step 1), but neutrophils adhere to the endothelial cells ( Step 2), pass through the endothelial cell layer (Step 3), remain in the space between the endothelial cells and the subendothelial basement membrane for longer than 30 min ( Step 4), as revealed by electron micrography, and finally penetrate the basement membrane of endothelial cells and pericytes (Step 5) . A glucocorticosteroid, dexamethasone, inhibits neutrophil migration by selective inhibition of the last step of the penetration of the basement membrane (Step 5) ."
The aim of the present study was to test whether neutrophils require matrix metalloproteinase in the process of migration from the venules or passage through the basement membrane. The results indicated that Step 6 We reported previously that dexamethasone inhibits migration at Step 5. This is in accord with the finding that induction of the gene expression of metalloproteinase in fibroblasts by the Arg-Gly-Asp sequence was inhibited by dexamethasone. 13 It cannot be concluded whether metalloproteinases are synthesized in neutrophils or the proteinases already synthesized are secreted, but these results, taken together, suggest that the period in which neutrophils remained in the space between the endothelial cells and the subendothelial basement membrane in the present experiment, may be necessary for the neutrophils to synthesize the metalloproteinase or to prepare to secrete this enzyme.
Our present results suggest that a metalloproteinase inhibitor such as FN-439 may be a potential therapeutic drug that would prevent neutrophil migration in inflammatory diseases such as rheumatoid arthritis. In conclusion, neutrophils may use metalloproteinase or collagenase/gelatinase, at the stage of passage through the subendothelial basement membrane during their transmigration.
